Product Code: ETC7548803 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neuroendocrine Tumors Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neuroendocrine Tumors Market Revenues & Volume, 2021 & 2031F |
3.3 India Neuroendocrine Tumors Market - Industry Life Cycle |
3.4 India Neuroendocrine Tumors Market - Porter's Five Forces |
3.5 India Neuroendocrine Tumors Market Revenues & Volume Share, By Classification, 2021 & 2031F |
3.6 India Neuroendocrine Tumors Market Revenues & Volume Share, By Site, 2021 & 2031F |
3.7 India Neuroendocrine Tumors Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.8 India Neuroendocrine Tumors Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 India Neuroendocrine Tumors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 India Neuroendocrine Tumors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 India Neuroendocrine Tumors Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Neuroendocrine Tumors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroendocrine tumors in India |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Advancements in diagnostic technologies for neuroendocrine tumors |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in certain regions of India |
4.3.2 High cost of neuroendocrine tumor treatments |
4.3.3 Lack of skilled healthcare professionals for managing neuroendocrine tumors |
5 India Neuroendocrine Tumors Market Trends |
6 India Neuroendocrine Tumors Market, By Types |
6.1 India Neuroendocrine Tumors Market, By Classification |
6.1.1 Overview and Analysis |
6.1.2 India Neuroendocrine Tumors Market Revenues & Volume, By Classification, 2021- 2031F |
6.1.3 India Neuroendocrine Tumors Market Revenues & Volume, By Functional Net, 2021- 2031F |
6.1.4 India Neuroendocrine Tumors Market Revenues & Volume, By Non-Functional Net, 2021- 2031F |
6.2 India Neuroendocrine Tumors Market, By Site |
6.2.1 Overview and Analysis |
6.2.2 India Neuroendocrine Tumors Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 India Neuroendocrine Tumors Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.4 India Neuroendocrine Tumors Market Revenues & Volume, By Gastrointestinal Tract (GI), 2021- 2031F |
6.2.5 India Neuroendocrine Tumors Market Revenues & Volume, By Appendicular, 2021- 2031F |
6.3 India Neuroendocrine Tumors Market, By Grade |
6.3.1 Overview and Analysis |
6.3.2 India Neuroendocrine Tumors Market Revenues & Volume, By Grade 1, 2021- 2031F |
6.3.3 India Neuroendocrine Tumors Market Revenues & Volume, By Low-Grade Tumor, 2021- 2031F |
6.3.4 India Neuroendocrine Tumors Market Revenues & Volume, By Grade 2, 2021- 2031F |
6.3.5 India Neuroendocrine Tumors Market Revenues & Volume, By Intermediate-Grade Tumor, 2021- 2031F |
6.3.6 India Neuroendocrine Tumors Market Revenues & Volume, By Grade 3, 2021- 2031F |
6.3.7 India Neuroendocrine Tumors Market Revenues & Volume, By High-Grade Tumor, 2021- 2031F |
6.4 India Neuroendocrine Tumors Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 India Neuroendocrine Tumors Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4.3 India Neuroendocrine Tumors Market Revenues & Volume, By Treatment, 2021- 2031F |
6.5 India Neuroendocrine Tumors Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 India Neuroendocrine Tumors Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.5.3 India Neuroendocrine Tumors Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.5.4 India Neuroendocrine Tumors Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021- 2031F |
6.5.5 India Neuroendocrine Tumors Market Revenues & Volume, By mTOR Inhibitors, 2021- 2031F |
6.5.6 India Neuroendocrine Tumors Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.5.7 India Neuroendocrine Tumors Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.5.8 India Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.5.9 India Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.6 India Neuroendocrine Tumors Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 India Neuroendocrine Tumors Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 India Neuroendocrine Tumors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.7 India Neuroendocrine Tumors Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 India Neuroendocrine Tumors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 India Neuroendocrine Tumors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.7.4 India Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.5 India Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.6 India Neuroendocrine Tumors Market Revenues & Volume, By Others, 2021- 2031F |
6.8 India Neuroendocrine Tumors Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 India Neuroendocrine Tumors Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 India Neuroendocrine Tumors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.8.4 India Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.5 India Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.6 India Neuroendocrine Tumors Market Revenues & Volume, By Other, 2021- 2031F |
7 India Neuroendocrine Tumors Market Import-Export Trade Statistics |
7.1 India Neuroendocrine Tumors Market Export to Major Countries |
7.2 India Neuroendocrine Tumors Market Imports from Major Countries |
8 India Neuroendocrine Tumors Market Key Performance Indicators |
8.1 Number of new diagnostic centers specializing in neuroendocrine tumors |
8.2 Adoption rate of advanced treatment modalities for neuroendocrine tumors |
8.3 Percentage increase in early-stage diagnosis of neuroendocrine tumors |
8.4 Patient satisfaction scores with neuroendocrine tumor care services |
8.5 Number of clinical trials for innovative neuroendocrine tumor treatments in India |
9 India Neuroendocrine Tumors Market - Opportunity Assessment |
9.1 India Neuroendocrine Tumors Market Opportunity Assessment, By Classification, 2021 & 2031F |
9.2 India Neuroendocrine Tumors Market Opportunity Assessment, By Site, 2021 & 2031F |
9.3 India Neuroendocrine Tumors Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.4 India Neuroendocrine Tumors Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 India Neuroendocrine Tumors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 India Neuroendocrine Tumors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 India Neuroendocrine Tumors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 India Neuroendocrine Tumors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Neuroendocrine Tumors Market - Competitive Landscape |
10.1 India Neuroendocrine Tumors Market Revenue Share, By Companies, 2024 |
10.2 India Neuroendocrine Tumors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |